Mohammad Ali Davarpanah

1.1k total citations
71 papers, 800 citations indexed

About

Mohammad Ali Davarpanah is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Mohammad Ali Davarpanah has authored 71 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 33 papers in Infectious Diseases and 15 papers in Hepatology. Recurrent topics in Mohammad Ali Davarpanah's work include Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease Diagnosis and Treatment (9 papers). Mohammad Ali Davarpanah is often cited by papers focused on Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease Diagnosis and Treatment (9 papers). Mohammad Ali Davarpanah collaborates with scholars based in Iran, United States and Russia. Mohammad Ali Davarpanah's co-authors include Aziz Japoni, Abdolvahab Alborzi, Afsaneh Vazin, Parisa Badiee, Davood Mehrabani, Khosrow Daneshbod, Sadegh Shirian, Abdolvahab Alborzi, Soha Namazi and Abbas Rezaianzadeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Digestive Diseases and Sciences and BMC Infectious Diseases.

In The Last Decade

Mohammad Ali Davarpanah

67 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Ali Davarpanah Iran 16 338 268 159 110 90 71 800
Ning‐Chi Wang Taiwan 17 285 0.8× 312 1.2× 80 0.5× 96 0.9× 88 1.0× 48 651
Haluk Eraksoy Türkiye 19 315 0.9× 289 1.1× 122 0.8× 177 1.6× 54 0.6× 78 1.0k
V. Mondain France 15 295 0.9× 349 1.3× 74 0.5× 56 0.5× 91 1.0× 54 705
Yitayih Wondimeneh Ethiopia 16 174 0.5× 253 0.9× 255 1.6× 50 0.5× 51 0.6× 35 681
Monique Keuter Netherlands 23 285 0.8× 558 2.1× 248 1.6× 47 0.4× 43 0.5× 43 1.3k
Patricia Pavèse France 24 644 1.9× 468 1.7× 209 1.3× 251 2.3× 69 0.8× 113 1.6k
F.K. Gould United Kingdom 17 482 1.4× 273 1.0× 97 0.6× 327 3.0× 66 0.7× 56 1.1k
Guilherme Santoro‐Lopes Brazil 21 435 1.3× 442 1.6× 64 0.4× 270 2.5× 44 0.5× 56 992
P. Weinbreck France 15 350 1.0× 267 1.0× 46 0.3× 55 0.5× 93 1.0× 60 818
Carlo Scolfaro Italy 15 329 1.0× 224 0.8× 73 0.5× 133 1.2× 122 1.4× 37 721

Countries citing papers authored by Mohammad Ali Davarpanah

Since Specialization
Citations

This map shows the geographic impact of Mohammad Ali Davarpanah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Ali Davarpanah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Ali Davarpanah more than expected).

Fields of papers citing papers by Mohammad Ali Davarpanah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Ali Davarpanah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Ali Davarpanah. The network helps show where Mohammad Ali Davarpanah may publish in the future.

Co-authorship network of co-authors of Mohammad Ali Davarpanah

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Ali Davarpanah. A scholar is included among the top collaborators of Mohammad Ali Davarpanah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Ali Davarpanah. Mohammad Ali Davarpanah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashempour, Tayebeh, et al.. (2024). Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults. BMC Infectious Diseases. 24(1). 358–358. 3 indexed citations
2.
Dehghani, Behzad, et al.. (2024). Frequency of Fusion Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients. AIDS Research and Human Retroviruses. 40(8). 471–481. 1 indexed citations
3.
Moayedi, Javad, et al.. (2024). Assessment of human Herpes Virus-8 infection in Iranian cirrhotic patients on the waiting list for liver transplantation: A cross-sectional analysis. New Microbes and New Infections. 62. 101496–101496. 1 indexed citations
4.
Davarpanah, Mohammad Ali, et al.. (2023). Aortoduodenal fistula and abdominal aortic aneurysm as a complication of Brucella Aortitis managed with Insitu aortic aneurysm repair: A case report. SHILAP Revista de lepidopterología. 11(12). e8269–e8269. 2 indexed citations
5.
Madani, Mahboobeh, et al.. (2022). Comparative assessment of the mouse immune responses to colistin-resistant and colistin-sensitive isolates of Acinetobacter baumannii. Microbial Pathogenesis. 173(Pt A). 105834–105834. 1 indexed citations
7.
Honarvar, Behnam, Mohsen Moghadami, Kamran Bagheri Lankarani, et al.. (2016). Brucellosis as a neglected disease in a neglected population: a seroepidemiological study of migratory nomads in the Fars province of Iran. Epidemiology and Infection. 145(3). 491–497. 7 indexed citations
8.
Davarpanah, Mohammad Ali, et al.. (2014). Surgeon′s satisfaction on the use of invented needle magnet in reducing the risk of sharp injuries in the operating room. Nigerian Medical Journal. 55(3). 220–220. 2 indexed citations
9.
Vazin, Afsaneh, et al.. (2012). Vancomycin utilization evaluation at hematology-oncology ward of a teaching hospital in iran.. PubMed Central. 26 indexed citations
10.
Badiee, Parisa, et al.. (2010). Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients.. PubMed. 13(4). 282–7. 73 indexed citations
11.
Mohraz, Minoo, et al.. (2009). A clinical trial on the efficacy of IMOD in AIDS patients. DARU Journal of Pharmaceutical Sciences. 17(4). 277–284. 14 indexed citations
12.
Davarpanah, Mohammad Ali, et al.. (2009). Association between PPD and QuantiFERON Gold TB Test in TB Infection and Disease among HIV- Infected Individuals in Southern Iran. Iranian Red Crescent Medical Journal. 11(1). 71–75. 6 indexed citations
13.
Mokhtari, A., et al.. (2009). The prevalence of Pediculus capitis among School Children in Fars Province, Southern Iran. SHILAP Revista de lepidopterología. 25 indexed citations
14.
Davarpanah, Mohammad Ali, Kamran Bagheri Lankarani, Davood Mehrabani, et al.. (2009). HEPATITIS C VIRUS GENOTYPE DISTRIBUTION IN SHIRAZ, SOUTHERN IRAN. Hepatitis Monthly. 9(223). 122–127. 21 indexed citations
15.
Davarpanah, Mohammad Ali, et al.. (2009). The prevalence of M. tuberculosis infection and disease in HIV positive individuals in Shiraz, Southern Iran.. Iranian Red Crescent Medical Journal. 11(2). 199–202. 4 indexed citations
16.
Japoni, Aziz, et al.. (2009). Multidrug-resistant bacteria isolated from intensive-care-unit patient samples. The Brazilian Journal of Infectious Diseases. 13(2). 118–22. 24 indexed citations
17.
Davarpanah, Mohammad Ali, et al.. (2008). HIGH-RISK BEHAVIORS IN HIV POSITIVE INDIVIDUALS IN SHIRAZ. Archives of Clinical Infectious Diseases. 3(4). 209–213. 2 indexed citations
18.
Davarpanah, Mohammad Ali, et al.. (2008). A 12-YEARS SURVEILLANCE OF POLIOMYELITIS AND ACUTE FLACCID PARALYSIS IN FARS PROVINCE, SOUTHERN IRAN. Iranian Red Crescent Medical Journal. 10(4). 288–293. 9 indexed citations
19.
Davarpanah, Mohammad Ali, et al.. (2007). Toxoplasmosis in HIV/AIDS patients in Shiraz, southern Iran. Iranian Red Crescent Medical Journal. 9(1). 22–27. 26 indexed citations
20.
Davarpanah, Mohammad Ali, et al.. (2002). SHOULD WE CONSIDER ANOTHER BOOSTER DOSE OF MEASLES VACCINE. Iranian journal of medical sciences. 27(1). 1–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026